Johnson & Johnson is acquiring full ownership of Verb Surgical, buying out the share held by Alphabet’s Verily Life Sciences LLC, after a four-year collaboration to develop a digital surgery platform.
J&J announced on 20 December its plans to acquire the remaining stake from Verily and move the robotic surgery platform to market alone. Verily CEO Andrew Conrad said he was...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?